{
  "id": "349b938a8886b4ca",
  "title": "STAT+: At ASH, Terns looks like rival to Novartis with drug for chronic myeloid leukemia",
  "description": "The ASH meeting included positive early results about a Terns drug for chronic myeloid leukemia and a Kura menin-blocker for acute myeloid leukemia.",
  "content": "The ASH meeting included positive early results about a Terns drug for chronic myeloid leukemia and a Kura menin-blocker for acute myeloid leukemia.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2025/12/08/ash-positive-results-leukemia-terns-rival-novartis/?utm_campaign=rss",
  "published_at": "2025-12-08T22:01:55+00:00",
  "fetched_at": "2025-12-09T00:22:19.510482+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: At ASH, Terns looks like rival to Novartis with drug for chronic myeloid leukemia",
    "description": "The ASH meeting included positive early results about a Terns drug for chronic myeloid leukemia and a Kura menin-blocker for acute myeloid leukemia.",
    "url": "https://www.statnews.com/2025/12/08/ash-positive-results-leukemia-terns-rival-novartis/?utm_campaign=rss",
    "published": "2025-12-08T22:01:55+00:00",
    "source": "STAT"
  }
}